AHIP Shelves the Plan to Sell Without a Unitholder Vote
At its June 18 meeting, American Hotel Income Properties dropped a proposed amendment that would have let its board sell substantially all assets without unitholder approval, mid-strategic-review.
American Hotel Income Properties just declined to hand its board a blank cheque. At its June 18 annual and special meeting, the Vancouver-based hotel trust elected all six director nominees — but with roughly 35% of votes withheld across the slate — and decided not to proceed with proposed amendments to its limited partnership agreement that would have let the board sell all or substantially all of AHIP's assets without unitholder approval. Management said it wants to finish its strategic review before revisiting governance changes.
| Metric | Value |
|---|---|
| Strategic-review advisor | Robert W. Baird |
| Q1 2026 revenue | US$36.4M (−25.2%) |
| Diluted FFO/unit | (US$0.03) |
| Convertible debenture | US$50M due Dec 31, 2026 |
| Unit price | ~CAD $0.50 |
Key Takeaways
- AHIP withdrew the amendment that would let the board sell assets unilaterally.
- A formal strategic review, advised by Robert W. Baird, could end in a full sale.
- An auditor going-concern flag ties to a US$50M debenture due December 2026.
A Veto Worth Keeping
The withdrawn amendment is the tell. AHIP's board opened a review of strategic alternatives on May 4, retaining Robert W. Baird to weigh individual hotel sales, portfolio transactions, refinancings, or a sale of substantially all remaining assets. Asking unitholders, weeks later, to pre-authorize a sale of everything without a further vote would have removed the one approval that still gives them leverage over the outcome. Pulling it — while roughly a third withheld support from directors — reads as a board choosing not to pick that fight before the review delivers.
The Numbers Behind the Review
The operating backdrop explains why the review exists. First-quarter revenue fell 25.2% to US$36.4 million as the portfolio shrank, and diluted FFO was negative US$0.03 per unit for a second consecutive quarter, with NOI down 35% to US$8.2 million. Same-store revenue actually rose 2.2%, so the decline is portfolio attrition, not a demand collapse — AHIP has sold 18 hotels in 2025 and seven more in 2026, with total dispositions since 2024 topping US$334 million. In April it also settled with its hotel manager, Aimbridge, paying US$2.3 million to retire a US$6.2 million deferred-fee liability and setting management-agreement termination for January 2027.
The Clock That Matters
The hard deadline is debt. AHIP's auditor flagged going-concern doubt in its 2025 year-end filings, tied to the US$50 million, 6.0% convertible debentures (HOT.DB.V) maturing December 31, 2026. The plan is to fund redemption from continuing hotel sales — which is exactly why the strategic review, the asset-sale pace, and the unitholder veto all point at the same question.
The Market's Read
Units trade near CAD $0.50, down roughly 89% from the 2013 IPO, and the debenture changes hands around 92 cents on the dollar at a 17.57% yield to maturity — the market pricing real doubt about the December redemption. The chart shows the recent range, with the June 18 meeting marked.
What to Watch
- The review's outcome — full sale, recapitalization, or wind-down, and on what timeline.
- Asset-sale proceeds — whether they cover the US$50M December debenture.
- Governance — whether the LP amendment returns once the review concludes.
The Bottom Line
This is end-game governance. With units near CAD $0.50, a going-concern flag, and a US$50 million debenture due December 31, AHIP's board chose not to ask unitholders to surrender their vote over a sale — for now. The strategic review opened in May is still the only question that matters; whether the remaining hotel sales raise enough to retire the debt will decide what unitholders actually recover.